Clinical Trial Update: Anlotinib and Irinotecan for Ewing Sarcoma [Phase 1, Phase 2]

View source ↗

Summary

Clinical Trial Update: a Phase 1/2 study evaluating the combination of Anlotinib and Irinotecan for metastatic Ewing sarcoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ewing Sarcoma

Drugs mentioned

• Anlotinib (anlotinib)
• Irinotecan (Irinotecan)

Snippet

Sponsor: Peking University People's Hospital | Conditions: Ewing's Tumor Metastatic | Phase 1, Phase 2 | Status: UNKNOWN